SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote (509)9/30/1997 5:18:00 PM
From: Taylor Caruthers   of 1728
 
BIOCHIP DEMAND TO GROW DRAMATICALLY IN NEXT 5 YEARS:

CS First Boston came out today to reitterate their Buy rating on AFFX.
Contents in the report state that as many as 14 million BIOCHIPS would be
needed by the year 2001. The value of these chips was estimated
conservatively at $900 Million plus. The demand for these chips comes
from three markets: 1.) Genomic applications, 2) pharmacogenomics, and
3) Dignostics. We remain a buy on Affymetrix stock. We estimate a loss
of $.86 in 1997, and a loss of $.80 in 1998. We estimate earnings of
$.03 in 1999.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News